Journal of Virology · 2018 · 31 citations · 50 references
Life SciencesBiologyMolecular BiologyMolecular VirologyStructural BiologyVirologyProtein StructureViral Gene ExpressionViral InfectionsViral PathogenesisViral StructureViral TranscriptionMarburg Virus DiseaseProtein Phosphatase CatalysisStructural VirologyViral Transcription Factors
The largest outbreak of MARV occurred in Angola in 2004 to 2005 and had a 90% case fatality rate. There are no approved treatments available for MARV. Development of antivirals as therapeutics requires a fundamental understanding of the viral life cycle. Because of the close similarity of MARV to another member of Filoviridae family, EBOV, it was assumed that the two viruses have similar mechanisms of regulation of transcription and replication. Here, characterization of the role of VP30 and its phosphorylation sites in transcription of the MARV genome demonstrated differences from those of EBOV. The identified phosphorylation sites appeared to inhibit transcription and appeared to be involved in interaction with both NP and VP35 ribonucleoproteins. A small molecule targeting PP1 inhibited transcription of the MARV genome, effectively suppressing replication of the viral particles. These data demonstrate the possibility developing antivirals based on compounds targeting PP1.
50
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Steffan N. Ho, Henry D. Hunt, Robert M. Horton et al. · Gene · 1989 · 7.5K citations
Structure validation by Cα geometry: ϕ,ψ and Cβ deviation
Simon C. Lovell, Ian Davis, W.B. Arendall et al. · Proteins Structure Function and Bioinformatics · 2003 · 4.6K citations